Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
NCT00759642
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
33
Enrollment
OTHER
Sponsor class
Stopped
IRB decision
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
lapatinib
Sponsor
University of Kansas Medical Center